Promotion and inhibition of cardiac hypertrophy by A-kinase anchor proteins

Can J Physiol Pharmacol. 2012 Sep;90(9):1161-70. doi: 10.1139/y2012-032. Epub 2012 Aug 2.

Abstract

Originally identified as mediators of cyclic adenosine monophosphate (cAMP) and protein kinase A signaling, A-kinase anchor proteins (AKAPs) are now recognized as a diverse family of molecular scaffolds capable of interacting with many other proteins. Members of the AKAP family within the heart can take on either pro- or anti-hypertrophic roles by interacting with a myriad of protein kinases and phosphatases in the process. AKAPs often form the core of large signaling complexes (or signalosomes) that allow multiple pathways to converge and functionally intertwine. Approximately 30% of AKAPs discovered to date are expressed in the heart, but the functions of many of these remain to be discovered. This review focuses on AKAPs that have been demonstrated to play roles in mediating cardiac hypertrophy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • A Kinase Anchor Proteins / genetics
  • A Kinase Anchor Proteins / metabolism
  • A Kinase Anchor Proteins / physiology*
  • Animals
  • Cardiomegaly / enzymology
  • Cardiomegaly / metabolism*
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Disease Progression
  • Humans
  • Myocardium / enzymology
  • Myocardium / metabolism*
  • Signal Transduction

Substances

  • A Kinase Anchor Proteins
  • Cyclic AMP-Dependent Protein Kinases